Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018461
Filing Date
2019-06-27
Accepted
2019-06-27 18:11:53
Documents
2
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3541
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4476
  Complete submission text file 0000899243-19-018461.txt   9470
Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94101
Business Address
Sinha Uma (Reporting) CIK: 0001742587 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38959 | Film No.: 19926694

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations